253 related articles for article (PubMed ID: 26081561)
1. Neurologic Complications of Chronic Kidney Disease.
Vellanki K; Bansal VK
Curr Neurol Neurosci Rep; 2015 Aug; 15(8):50. PubMed ID: 26081561
[TBL] [Abstract][Full Text] [Related]
2. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
[TBL] [Abstract][Full Text] [Related]
3. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
[TBL] [Abstract][Full Text] [Related]
4. Management of atrial fibrillation in chronic kidney disease: double trouble.
Nimmo C; Wright M; Goldsmith D
Am Heart J; 2013 Aug; 166(2):230-9. PubMed ID: 23895805
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
Salim I; Al Suwaidi J; Ghadban W; Salam AM
Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
[TBL] [Abstract][Full Text] [Related]
6. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines.
Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J
Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343
[TBL] [Abstract][Full Text] [Related]
7. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
8. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
[TBL] [Abstract][Full Text] [Related]
9. [NOACs and Chronic kidney disease].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Mar; 34(Suppl 69):188-204. PubMed ID: 28682039
[TBL] [Abstract][Full Text] [Related]
10. Atrial Fibrillation in Patients with Chronic Kidney Disease.
Kotalczyk A; Ding WY; Wong CF; Rao A; Gupta D; Lip GYH
Cardiol Clin; 2021 Aug; 39(3):435-446. PubMed ID: 34247756
[TBL] [Abstract][Full Text] [Related]
11. New oral anticoagulants in patients with chronic kidney disease.
Belmar Vega L; de Francisco ALM; Bada da Silva J; Galván Espinoza L; Fernández Fresnedo G
Nefrologia; 2017; 37(3):244-252. PubMed ID: 27939514
[TBL] [Abstract][Full Text] [Related]
12. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
13. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease.
Turagam MK; Addepally NS; Velagapudi P
Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517
[TBL] [Abstract][Full Text] [Related]
14. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
[TBL] [Abstract][Full Text] [Related]
15. The Quandary of Oral Anticoagulation in Patients With Atrial Fibrillation and Chronic Kidney Disease.
Schwartzenberg S; Lev EI; Sagie A; Korzets A; Kornowski R
Am J Cardiol; 2016 Feb; 117(3):477-82. PubMed ID: 26721651
[TBL] [Abstract][Full Text] [Related]
16. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
17. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
Yang F; Hellyer JA; Than C; Ullal AJ; Kaiser DW; Heidenreich PA; Hoang DD; Winkelmayer WC; Schmitt S; Frayne SM; Phibbs CS; Turakhia MP
Heart; 2017 Jun; 103(11):818-826. PubMed ID: 27852694
[TBL] [Abstract][Full Text] [Related]
18. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
[TBL] [Abstract][Full Text] [Related]
19. The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.
Franczyk B; Gluba-Brzózka A; Ciałkowska-Rysz A; Banach M; Rysz J
Curr Vasc Pharmacol; 2016; 14(3):260-5. PubMed ID: 26769703
[TBL] [Abstract][Full Text] [Related]
20. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
